Sutton Place Investors’s Pfizer PFE Stock Holding History

Sutton Place Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Sell	9,045 -910	-9%	-$24.2K	0.14%	116
2025 Q4	$248K	Buy	9,955 +433	+5%	+$10.9K	0.14%	115
2025 Q3	$243K	Sell	9,522 -137	-1%	-$3.38K	0.14%	112
2025 Q2	$234K	Buy	9,659 +826	+9%	+$19.3K	0.14%	109
2025 Q1	$224K	Buy	8,833 +472	+6%	+$12.4K	0.15%	103
2024 Q4	$222K	Sell	8,361 -5,102	-38%	-$138K	0.13%	122
2024 Q3	$390K	Buy	13,463 +747	+6%	+$21.8K	0.24%	87
2024 Q2	$356K	Sell	12,716 -21,484	-63%	-$591K	0.24%	83
2024 Q1	$949K	Buy	34,200 +6,343	+23%	+$176K	0.47%	66
2023 Q4	$802K	Buy	+27,857	New	+$842K	0.58%	58

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Sutton Place Investors's PFE Position: Q1 2026 in Review

Sutton Place Investors reduced its Pfizer (PFE) stake by 9.1% in Q1 2026, selling an estimated $24.2K and leaving 9,045 shares worth $254K. The position accounts for 0.14% of the portfolio, ranked #116.

Sutton Place Investors first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $949K in Q1 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Sutton Place Investors held 9,045 shares of Pfizer worth $254K as of Q1 2026.
Sutton Place Investors sold 910 Pfizer shares in Q1 2026, an estimated $24.2K.
Pfizer made up 0.14% of Sutton Place Investors's portfolio in Q1 2026, its #116 holding.
Sutton Place Investors first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
Sutton Place Investors's Pfizer position peaked at $949K in Q1 2024.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sutton Place Investors's 13F filing for Q1 2026, filed 22 Apr 2026.